Provexis (PXS)

Sector:

Food

Index:

FTSE AIM All-Share

0.50p
   
  • Change Today:
      0.001p
  • 52 Week High: 0.70
  • 52 Week Low: 0.45
  • Currency: UK Pounds
  • Shares Issued: 2,345.89m
  • Volume: 138,132
  • Market Cap: £11.69m
  • RiskGrade: 364
  • Beta: 0.00

Provexis reaches retail agreement with Holland and Barrett

By Iain Gilbert

Date: Monday 25 Jun 2018

LONDON (ShareCast) - (Sharecast News) - AIM-listed functional food developer Provexis has secured a listing with high street health and wellbeing retailer Holland and Barrett for its Fruitflow dietary supplement product.




Fruitflow+ Omega-3, Provexis' two-in-one supplement, which supports healthy blood flow and normal heart function, will be listed in more than 660 Holland and Barrett stores across the UK and Ireland, together with Holland & Barrett Online, giving the supplement product widespread consumer exposure.

Holland and Barrett staff will be trained to understand and communicate the benefits of Fruitflow+ Omega-3 to prospective customers ahead of its launch in-store and online in August.

In June 2017, the Company secured a listing for the product with Amazon.co.uk.

Dawson Buck, chairman of Provexis, said, "The listing will help raise awareness of the proven benefits of Fruitflow across a substantial consumer audience, and the company's expanding Fruitflow+ dietary supplement business is expected to provide the company with an additional long-term income and profit stream."

"We look forward to working with Holland and Barrett to maximise recommendation, trial and repeat purchase of the product," added Buck.

As of 1020 BST, Provexis shares had shot up 16.25% to 0.46p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Provexis Market Data

Currency UK Pounds
Share Price 0.50p
Change Today 0.001p
% Change 0.20 %
52 Week High 0.70
52 Week Low 0.45
Volume 138,132
Shares Issued 2,345.89m
Market Cap £11.69m
Beta 0.00
RiskGrade 364

Provexis Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.2% below the market average39.2% below the market average39.2% below the market average39.2% below the market average39.2% below the market average
25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average
Price Trend
57.26% below the market average57.26% below the market average57.26% below the market average57.26% below the market average57.26% below the market average
74.19% below the sector average74.19% below the sector average74.19% below the sector average74.19% below the sector average74.19% below the sector average
Income Not Available
Growth
50.75% above the market average50.75% above the market average50.75% above the market average50.75% above the market average50.75% above the market average
70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average

Provexis Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
13:32 38,095 @ 0.53p
11:43 100,037 @ 0.46p

Provexis Key Personnel

CEO Ian Ford

Top of Page